Insulet (PODD) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Insulet (PODD) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 12.44% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 11.36% |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 6.67% |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 6.92% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 19.21% |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 6.67% |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 2.86% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 8.23% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 5.69% |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 19.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.18% |
| Mar 31, 2026 | 15.54% |
| Dec 31, 2025 | 13.33% |
| Sep 30, 2025 | 3.02% |
| Jun 30, 2025 | 6.27% |
| Mar 31, 2025 | 7.64% |
| Dec 31, 2024 | 8.75% |
| Sep 30, 2024 | 8.27% |
| Jun 30, 2024 | 12.70% |
| Mar 31, 2024 | 11.92% |
| Dec 31, 2023 | 10.84% |
| Sep 30, 2023 | 17.37% |
| Jun 30, 2023 | 12.26% |
| Mar 31, 2023 | 10.85% |
| Dec 31, 2022 | 11.82% |
| Sep 30, 2022 | 7.31% |
| Jun 30, 2022 | 5.99% |
| Mar 31, 2022 | 8.09% |
| Dec 31, 2021 | 12.07% |
| Sep 30, 2021 | 14.74% |